Literature DB >> 33503486

Hyaluronic acid and albumin based nanoparticles for drug delivery.

Can Lei1, Xiu-Ran Liu1, Quan-Bing Chen1, You Li1, Jia-Li Zhou1, Ling-Yue Zhou1, Tao Zou2.   

Abstract

Albumin, a multifunctional protein, is widely used to prepare nanocarriers. Hyaluronic acid (HA) is a natural glycosaminoglycan that can specifically bind receptors, such as cluster of differentiation-44. Therefore, HA is commonly used as ligands for the surface modification of versatile nanocarriers. The combined utilization of albumin and HA as nanocarriers shows outstanding superiorities including efficient targeting, reducible particle size, pH and/or hyaluronidase sensitive drug release, combining capacity for various drugs, biocompatibility, non-immunogenicity, biodegradability and high stability. However, to the best of our knowledge, HA and albumin based nanoparticles have not been reviewed for drug delivery so far. This review involves the introduction of the essential information of HA and albumin as well as a brief presentation of the preparation methods of HA and albumin based nanocarriers. Moreover, the application of HA and albumin based nanoparticles as drug delivery carriers in tumors, joints, vitreum and skin tissue is systematically discussed with the potential and prospect in combined therapy and theranostics. In addition, the unique advantages of the HA and albumin based nanoparticles and their contributions to the improvement of drug delivery systems are further expounded in detail.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Albumin; Combined therapy; Drug delivery; Hyaluronic acid; Nanoparticle; Theranostics

Year:  2021        PMID: 33503486     DOI: 10.1016/j.jconrel.2021.01.033

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  12 in total

Review 1.  Hyaluronic Acid-Conjugated Carbon Nanomaterials for Enhanced Tumour Targeting Ability.

Authors:  Oisin Kearns; Adalberto Camisasca; Silvia Giordani
Journal:  Molecules       Date:  2021-12-22       Impact factor: 4.411

Review 2.  Protein nanoparticles directed cancer imaging and therapy.

Authors:  Yao Miao; Tao Yang; Shuxu Yang; Mingying Yang; Chuanbin Mao
Journal:  Nano Converg       Date:  2022-01-08

3.  Orally administered intelligent self-ablating nanoparticles: a new approach to improve drug cellular uptake and intestinal absorption.

Authors:  Yanzi Liang; Ruihuan Ding; Huihui Wang; Lanze Liu; Jibiao He; Yuping Tao; Zhenyu Zhao; Jie Zhang; Aiping Wang; Kaoxiang Sun; Youxin Li; Yanan Shi
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

4.  Albumin-Hyaluronan Interactions: Influence of Ionic Composition Probed by Molecular Dynamics.

Authors:  Piotr Bełdowski; Maciej Przybyłek; Przemysław Raczyński; Andra Dedinaite; Krzysztof Górny; Florian Wieland; Zbigniew Dendzik; Alina Sionkowska; Per M Claesson
Journal:  Int J Mol Sci       Date:  2021-11-16       Impact factor: 5.923

5.  On-demand assembly of polymeric nanoparticles for longer-blood-circulation and disassembly in tumor for boosting sonodynamic therapy.

Authors:  Mei Wen; Nuo Yu; Shiwen Wu; Mengmeng Huang; Pu Qiu; Qian Ren; Meifang Zhu; Zhigang Chen
Journal:  Bioact Mater       Date:  2022-03-12

6.  Application of Biomaterials in Tendon Injury Healing and Adhesion in Sports.

Authors:  Rui Zhang
Journal:  J Healthc Eng       Date:  2022-04-12       Impact factor: 3.822

Review 7.  Hyaluronic Acid: A Review of the Drug Delivery Capabilities of This Naturally Occurring Polysaccharide.

Authors:  Ciara Buckley; Emma J Murphy; Therese R Montgomery; Ian Major
Journal:  Polymers (Basel)       Date:  2022-08-23       Impact factor: 4.967

Review 8.  Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies.

Authors:  Hailong Tian; Tingting Zhang; Siyuan Qin; Zhao Huang; Li Zhou; Jiayan Shi; Edouard C Nice; Na Xie; Canhua Huang; Zhisen Shen
Journal:  J Hematol Oncol       Date:  2022-09-12       Impact factor: 23.168

Review 9.  Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies.

Authors:  Monica Mossenta; Davide Busato; Michele Dal Bo; Paolo Macor; Giuseppe Toffoli
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

10.  Design of Targeted Flurbiprofen Biomimetic Nanoparticles for Management of Arthritis: In Vitro and In Vivo Appraisal.

Authors:  Hagar I Mohamed; Amal H El-Kamel; Ghada O Hammad; Lamia A Heikal
Journal:  Pharmaceutics       Date:  2022-01-07       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.